[The fatty liver epidemic: An analysis from the primary care]
- PMID: 31718777
- PMCID: PMC6945131
- DOI: 10.1016/j.aprim.2019.09.002
[The fatty liver epidemic: An analysis from the primary care]
Comment in
-
[Ultrasonography in non-alcoholic fatty liver disease].Aten Primaria. 2020 Nov;52(9):664-665. doi: 10.1016/j.aprim.2020.04.005. Epub 2020 May 29. Aten Primaria. 2020. PMID: 32475695 Free PMC article. Spanish. No abstract available.
References
-
- Chalasani N., Younossi Z., Lavine J.E., Charlton M., Cusi K., Rinella M. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357. - PubMed
-
- Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed
-
- Younossi Z., Anstee Q.M., Marietti M., Hardy T., Henry L., Eslam M. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20. - PubMed
-
- Younossi Z., Stepanova M., Ong J.P., Jacobson I.M., Bugianesi E., Duseja A. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2019;17:748–755. - PubMed
-
- Dyson J., Jaques B., Chattopadyhay D., Lochan R., Graham J., Das D. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J. Hepatol. 2014;60:110–117. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
